Pratteln, Switzerland, April 16, 2025 – Santhera Pharmaceuticals (SIX: SANN) announces the latest progress on the commercial rollout of AGAMREE® for the treatment of Duchenne Muscular Dystrophy (DMD).

The European Commission on Tuesday authorized the use of Eisai and Biogen's drug to treat some patients with mild cognitive impairment in the early stages of Alzheimer's disease, ending a more than ...

Nearly three dozen global pharmaceutical companies, in a letter to the head of the European Commission, demanded help to ...

The European Commission has for the first time approved an Alzheimer's therapy that targets the underlying disease processes.

Raw material dependency and transport bottlenecks, not just production capacity, are the key challenges facing the EU's radiopharmaceutical sector, according to the European Medicines Agency (EMA). Vi ...

Norgine and Theravia announced today that they have entered into a definitive agreement under which Norgine will acquire Theravia, ...

Pharmacovigilance evolves with technology, employing active surveillance to detect drug-related issues and ensure safety in ...

This article examines post-market drug safety, highlighting surveillance mechanisms, regulatory responses, and case studies ...

Organon and Shanghai Henlius Biotech have announced that the European Medicines Agency (EMA) has validated a marketing authorisation application for HLX11, a biosimilar candidate referencing Roche’s ...

The world is facing two immediate health crises concerning drugs and vaccines: affordable and reliable access to life-sparing medicines and the safety and reliability of those medicines.

The Eagles general manager discussed plenty of topics, from a series of free-agency signings, Dallas Goedert’s uncertain future with the team, and the rationale behind moving on from players like ...